Evolent Health Management
Management criteria checks 2/4
Evolent Health's CEO is Seth Blackley, appointed in Jan 2011, has a tenure of 14.33 years. total yearly compensation is $11.14M, comprised of 7.2% salary and 92.8% bonuses, including company stock and options. directly owns 0.38% of the company’s shares, worth $3.25M. The average tenure of the management team and the board of directors is 4.2 years and 4.4 years respectively.
Key information
Seth Blackley
Chief executive officer
US$11.1m
Total compensation
| CEO salary percentage | 7.18% |
| CEO tenure | 14.3yrs |
| CEO ownership | 0.4% |
| Management average tenure | 4.2yrs |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
Why Investors Shouldn't Be Surprised By Evolent Health, Inc.'s (NYSE:EVH) 25% Share Price Plunge
May 30
New England Contract And Automation Will Drive Efficiency
Strong organic growth through expanded client agreements and sales pipeline is expected to boost revenue significantly.Benign Growth For Evolent Health, Inc. (NYSE:EVH) Underpins Its Share Price
Apr 14Evolent Health: Health Insurance Headwinds Aren't Helping Business - Rating Downgrade
Feb 27Analysts Have Lowered Expectations For Evolent Health, Inc. (NYSE:EVH) After Its Latest Results
Feb 22We Think Evolent Health (NYSE:EVH) Can Stay On Top Of Its Debt
Jan 04Evolent Health: A Shot At Revival After Market Bruising
Nov 12Take Care Before Jumping Onto Evolent Health, Inc. (NYSE:EVH) Even Though It's 49% Cheaper
Nov 09We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)
Nov 07Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet
Sep 19Evolent Health: Let The Bidding Begin
Aug 23Potential Upside For Evolent Health, Inc. (NYSE:EVH) Not Without Risk
Jul 29Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher
Jul 01Evolent Health: Recent Pullback, A Buying Opportunity Or Not? (Rating Downgrade)
May 22These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well
May 05Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares
Apr 08Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital
Mar 12Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt
Jan 17Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)
Dec 21Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital
Nov 30A First Evaluation On Evolent Health
Oct 04Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?
Sep 29There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital
Sep 01An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued
Aug 04Evolent Health: Business Economics Still Appealing, Reiterate Buy
Jul 19Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely
Jun 14Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt
May 30An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued
May 02Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue
Apr 17Evolent Health GAAP EPS of $0.11 beats by $0.13, revenue of $382.4M beats by $9.47M
Feb 22Is Evolent Health (NYSE:EVH) A Risky Investment?
Feb 19Evolent Health: Strengthening Fundamentals, Investing At High Rates Of Return
Feb 15CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | -US$140m |
| Dec 31 2024 | US$11m | US$800k | -US$93m |
| Sep 30 2024 | n/a | n/a | -US$104m |
| Jun 30 2024 | n/a | n/a | -US$106m |
| Mar 31 2024 | n/a | n/a | -US$141m |
| Dec 31 2023 | US$9m | US$783k | -US$142m |
| Sep 30 2023 | n/a | n/a | -US$112m |
| Jun 30 2023 | n/a | n/a | -US$77m |
| Mar 31 2023 | n/a | n/a | -US$40m |
| Dec 31 2022 | US$8m | US$683k | -US$19m |
| Sep 30 2022 | n/a | n/a | -US$4m |
| Jun 30 2022 | n/a | n/a | -US$19m |
| Mar 31 2022 | n/a | n/a | -US$24m |
| Dec 31 2021 | US$7m | US$600k | -US$30m |
| Sep 30 2021 | n/a | n/a | -US$45m |
| Jun 30 2021 | n/a | n/a | -US$68m |
| Mar 31 2021 | n/a | n/a | -US$261m |
| Dec 31 2020 | US$4m | US$438k | -US$328m |
| Sep 30 2020 | n/a | n/a | -US$515m |
| Jun 30 2020 | n/a | n/a | -US$504m |
| Mar 31 2020 | n/a | n/a | -US$334m |
| Dec 31 2019 | US$3m | US$400k | -US$304m |
| Sep 30 2019 | n/a | n/a | -US$121m |
| Jun 30 2019 | n/a | n/a | -US$107m |
| Mar 31 2019 | n/a | n/a | -US$86m |
| Dec 31 2018 | US$2m | US$400k | -US$53m |
Compensation vs Market: Seth's total compensation ($USD11.14M) is above average for companies of similar size in the US market ($USD3.97M).
Compensation vs Earnings: Seth's compensation has increased whilst the company is unprofitable.
CEO
Seth Blackley (45 yo)
Mr. Seth Barrie Blackley is Director of Iodine Software, LLC. He serves as Chief Executive Officer at Evolent Health, Inc. since October 1, 2020. He serves as President of True Health Indiana, Inc. (True H...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 14.3yrs | US$11.14m | 0.38% $ 3.3m | |
| President | 2.7yrs | US$7.48m | 0.25% $ 2.2m | |
| Chief Financial Officer | 5.8yrs | US$4.81m | 0.14% $ 1.2m | |
| Chief Operating Officer | 1.8yrs | US$2.01m | 0.038% $ 325.9k | |
| Chief Legal Officer | 11.3yrs | US$1.97m | 0.11% $ 966.6k | |
| Chief Accounting Officer | 4.9yrs | US$634.88k | 0.030% $ 253.5k | |
| Chief Technology Officer | no data | no data | no data | |
| Chief Information Officer | 1.3yrs | no data | no data | |
| Vice President of Investor Relations | 3.4yrs | no data | no data | |
| Chief People Officer | less than a year | no data | no data | |
| Chief Strategy Officer | 13.3yrs | no data | no data | |
| President of Performance Suite | no data | no data | no data |
Experienced Management: EVH's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 7.1yrs | US$11.14m | 0.38% $ 3.3m | |
| Independent Director | 5.3yrs | US$285.25k | 0.052% $ 447.1k | |
| Independent Director | 1.9yrs | US$265.25k | 0.032% $ 270.9k | |
| Independent Director | 1.3yrs | US$318.75k | 0.011% $ 92.9k | |
| Independent Chairperson of the Board & Lead Independent Director | 9.5yrs | US$382.75k | 0.038% $ 322.7k | |
| Independent Director | 13.8yrs | US$290.25k | 0.054% $ 463.4k | |
| Independent Director | 4.3yrs | US$290.25k | 0.027% $ 234.5k | |
| Independent Director | 4.4yrs | US$282.50k | 0.021% $ 178.7k | |
| Independent Director | 1.3yrs | no data | 0.017% $ 147.4k | |
| Independent Director | 1.8yrs | US$265.25k | 0.0038% $ 32.4k |
Experienced Board: EVH's board of directors are considered experienced (4.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/30 13:32 |
| End of Day Share Price | 2025/05/30 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Evolent Health, Inc. is covered by 23 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Gillmor | Baird |
| David Larsen | BTIG |
| Richard Close | Canaccord Genuity |